These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia. Ishikawa M; Namiki A; Kubota T; Yajima S; Fukazawa M; Moroi M; Sugi K Intern Med; 2006; 45(2):51-5. PubMed ID: 16484739 [TBL] [Abstract][Full Text] [Related]
5. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors. Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417 [TBL] [Abstract][Full Text] [Related]
6. Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Pallebage-Gamarallage M; Lam V; Takechi R; Galloway S; Clark K; Mamo J Lipids Health Dis; 2012 Sep; 11():117. PubMed ID: 22978403 [TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels. Martínez-González J; Alfón J; Berrozpe M; Badimon L Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate. Zhang N; Huan Y; Huang H; Song GM; Sun SJ; Shen ZF Acta Pharmacol Sin; 2010 Jan; 31(1):35-42. PubMed ID: 20023693 [TBL] [Abstract][Full Text] [Related]
9. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744 [TBL] [Abstract][Full Text] [Related]
10. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs. Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693 [TBL] [Abstract][Full Text] [Related]
11. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588 [TBL] [Abstract][Full Text] [Related]
13. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. Cheung RC; Morrell JM; Kallend D; Watkins C; Schuster H Int J Cardiol; 2005 Apr; 100(2):309-16. PubMed ID: 15823640 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317 [TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267 [TBL] [Abstract][Full Text] [Related]
16. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698 [TBL] [Abstract][Full Text] [Related]
17. Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia. Mazza F; Stefanutti C; Di Giacomo S; Vivenzio A; Fraone N; Mazzarella B; Bucci A Am J Cardiovasc Drugs; 2008; 8(4):265-70. PubMed ID: 18690760 [TBL] [Abstract][Full Text] [Related]
18. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study. Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H; J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789 [TBL] [Abstract][Full Text] [Related]